23 results
424B4
CGTX
Cognition Therapeutics Inc
8 Jan 24
Prospectus supplement with pricing info
4:11pm
and restated certificate of incorporation and amended and restated bylaws may discourage stockholders from bringing a lawsuit against our directors
424B4
CGTX
Cognition Therapeutics Inc
14 Nov 22
Prospectus supplement with pricing info
6:02am
be sent to us once the third party’s ANDA is accepted for filing by the FDA. We may then initiate a lawsuit to defend the patents identified in the notice … . The filing of a patent infringement lawsuit within 45 days of receipt of the notice automatically prevents the FDA from approving the third party’s
10-Q
2021 Q3
CGTX
Cognition Therapeutics Inc
17 Nov 21
Quarterly report
5:15pm
for filing by the FDA. We may then initiate a lawsuit to defend the patents identified in the notice. The filing of a patent infringement lawsuit within 45 … the patent expires, the lawsuit is settled, or the court reaches a decision in the infringement lawsuit in favor of the third party. If we do not file
DRS
zm8bj1 93l4f
20 Oct 22
Draft registration statement
12:00am
S-3
c8x gnuzg
23 Dec 22
Shelf registration
4:16pm
10-K
wh11njs7zhp jvx
30 Mar 22
Annual report
7:40am
S-1
vb6 trwk815mc
19 Jul 21
IPO registration
7:02am
424B4
lzm 8cvsovqjmekv66
12 Oct 21
Prospectus supplement with pricing info
4:11pm
DRS
8r6ospm2a7t6
7 May 21
Draft registration statement
12:00am
DRS/A
vx9ycfp
23 Jun 21
Draft registration statement (amended)
12:00am
S-1
EX-10.4
6g9 bg0s0npdm9
19 Jul 21
IPO registration
7:02am